Return to study ST003151 main page

Download data matrix(BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 Reversed phase NEGATIVE ION MODE)

Download data matrix(BT474 breast cancer cell line grown in 20% D2O-containing RPMI-1640 medium treated with Fasnall and GSK2194069 Reversed phase POSITIVE ION MODE)

AnalysisSamplesFactorsUnits
Reversed phase NEGATIVE ION MODE05_FFA_D2O_BT474_GSK0001Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 nM GSK2194069AU
Reversed phase NEGATIVE ION MODE12_FFA_D2O_BT474_GSK0001Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 nM GSK2194069AU
Reversed phase NEGATIVE ION MODE19_FFA_D2O_BT474_GSK0001Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 nM GSK2194069AU
Reversed phase NEGATIVE ION MODE08_FFA_D2O_BT474_Fasnall01Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 uM FasnallAU
Reversed phase NEGATIVE ION MODE15_FFA_D2O_BT474_Fasnall01Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 uM FasnallAU
Reversed phase NEGATIVE ION MODE22_FFA_D2O_BT474_Fasnall01Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 uM FasnallAU
Reversed phase NEGATIVE ION MODE07_FFA_D2O_BT474_GSK1000Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 uM GSK2194069AU
Reversed phase NEGATIVE ION MODE14_FFA_D2O_BT474_GSK1000Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 uM GSK2194069AU
Reversed phase NEGATIVE ION MODE21_FFA_D2O_BT474_GSK1000Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 uM GSK2194069AU
Reversed phase NEGATIVE ION MODE06_FFA_D2O_BT474_GSK0040Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:40 nM GSK2194069AU
Reversed phase NEGATIVE ION MODE13_FFA_D2O_BT474_GSK0040Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:40 nM GSK2194069AU
Reversed phase NEGATIVE ION MODE20_FFA_D2O_BT474_GSK0040Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:40 nM GSK2194069AU
Reversed phase NEGATIVE ION MODE10_FFA_D2O_BT474_Fasnall40Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:40 uM FasnallAU
Reversed phase NEGATIVE ION MODE17_FFA_D2O_BT474_Fasnall40Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:40 uM FasnallAU
Reversed phase NEGATIVE ION MODE24_FFA_D2O_BT474_Fasnall40Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:40 uM FasnallAU
Reversed phase NEGATIVE ION MODE09_FFA_D2O_BT474_Fasnall05Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:5 uM FasnallAU
Reversed phase NEGATIVE ION MODE16_FFA_D2O_BT474_Fasnall05Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:5 uM FasnallAU
Reversed phase NEGATIVE ION MODE23_FFA_D2O_BT474_Fasnall05Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:5 uM FasnallAU
Reversed phase NEGATIVE ION MODE04_FFA_D2O_BT474_ControlSample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:VehicleAU
Reversed phase NEGATIVE ION MODE11_FFA_D2O_BT474_ControlSample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:VehicleAU
Reversed phase NEGATIVE ION MODE18_FFA_D2O_BT474_ControlSample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:VehicleAU
Reversed phase NEGATIVE ION MODE01_FFA_BlankSample source:BT-474 cell lipid extract | Isotopic Tracer:NA | Drug Treatment:NAAU
Reversed phase NEGATIVE ION MODE02_FFA_BlankSample source:BT-474 cell lipid extract | Isotopic Tracer:NA | Drug Treatment:NAAU
Reversed phase NEGATIVE ION MODE03_FFA_BlankSample source:BT-474 cell lipid extract | Isotopic Tracer:NA | Drug Treatment:NAAU
Reversed phase NEGATIVE ION MODE25_FFA_BlankSample source:BT-474 cell lipid extract | Isotopic Tracer:NA | Drug Treatment:NAAU
Reversed phase NEGATIVE ION MODE26_FFA_BlankSample source:BT-474 cell lipid extract | Isotopic Tracer:NA | Drug Treatment:NAAU
Reversed phase NEGATIVE ION MODE27_FFA_BlankSample source:BT-474 cell lipid extract | Isotopic Tracer:NA | Drug Treatment:NAAU
Reversed phase POSITIVE ION MODE05_FFA_D2O_BT474_GSK0001Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 nM GSK2194069AU
Reversed phase POSITIVE ION MODE12_FFA_D2O_BT474_GSK0001Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 nM GSK2194069AU
Reversed phase POSITIVE ION MODE19_FFA_D2O_BT474_GSK0001Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 nM GSK2194069AU
Reversed phase POSITIVE ION MODE08_FFA_D2O_BT474_Fasnall01Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 uM FasnallAU
Reversed phase POSITIVE ION MODE15_FFA_D2O_BT474_Fasnall01Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 uM FasnallAU
Reversed phase POSITIVE ION MODE22_FFA_D2O_BT474_Fasnall01Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 uM FasnallAU
Reversed phase POSITIVE ION MODE07_FFA_D2O_BT474_GSK1000Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 uM GSK2194069AU
Reversed phase POSITIVE ION MODE14_FFA_D2O_BT474_GSK1000Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 uM GSK2194069AU
Reversed phase POSITIVE ION MODE21_FFA_D2O_BT474_GSK1000Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:1 uM GSK2194069AU
Reversed phase POSITIVE ION MODE06_FFA_D2O_BT474_GSK0040Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:40 nM GSK2194069AU
Reversed phase POSITIVE ION MODE13_FFA_D2O_BT474_GSK0040Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:40 nM GSK2194069AU
Reversed phase POSITIVE ION MODE20_FFA_D2O_BT474_GSK0040Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:40 nM GSK2194069AU
Reversed phase POSITIVE ION MODE10_FFA_D2O_BT474_Fasnall40Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:40 uM FasnallAU
Reversed phase POSITIVE ION MODE17_FFA_D2O_BT474_Fasnall40Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:40 uM FasnallAU
Reversed phase POSITIVE ION MODE24_FFA_D2O_BT474_Fasnall40Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:40 uM FasnallAU
Reversed phase POSITIVE ION MODE09_FFA_D2O_BT474_Fasnall05Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:5 uM FasnallAU
Reversed phase POSITIVE ION MODE16_FFA_D2O_BT474_Fasnall05Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:5 uM FasnallAU
Reversed phase POSITIVE ION MODE23_FFA_D2O_BT474_Fasnall05Sample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:5 uM FasnallAU
Reversed phase POSITIVE ION MODE04_FFA_D2O_BT474_ControlSample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:VehicleAU
Reversed phase POSITIVE ION MODE11_FFA_D2O_BT474_ControlSample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:VehicleAU
Reversed phase POSITIVE ION MODE18_FFA_D2O_BT474_ControlSample source:BT-474 cell lipid extract | Isotopic Tracer:20% D2O | Drug Treatment:VehicleAU
Reversed phase POSITIVE ION MODE01_FFA_BlankSample source:BT-474 cell lipid extract | Isotopic Tracer:NA | Drug Treatment:NAAU
Reversed phase POSITIVE ION MODE02_FFA_BlankSample source:BT-474 cell lipid extract | Isotopic Tracer:NA | Drug Treatment:NAAU
Reversed phase POSITIVE ION MODE03_FFA_BlankSample source:BT-474 cell lipid extract | Isotopic Tracer:NA | Drug Treatment:NAAU
Reversed phase POSITIVE ION MODE25_FFA_BlankSample source:BT-474 cell lipid extract | Isotopic Tracer:NA | Drug Treatment:NAAU
Reversed phase POSITIVE ION MODE26_FFA_BlankSample source:BT-474 cell lipid extract | Isotopic Tracer:NA | Drug Treatment:NAAU
Reversed phase POSITIVE ION MODE27_FFA_BlankSample source:BT-474 cell lipid extract | Isotopic Tracer:NA | Drug Treatment:NAAU
  logo